NDC product
Me NaPhos MB Hyo 1
NDC 58657-454 · Method Pharmaceuticals
Key facts
| Product NDC | 58657-454 |
|---|---|
| Proprietary name | Me NaPhos MB Hyo 1 |
| Nonproprietary name | Urinary Antiseptic Antispasmodic |
| Substances | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, METHYLENE BLUE ANHYDROUS, HYOSCYAMINE SULFATE ANHYDROUS |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Method Pharmaceuticals |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC] |
| Marketing start | Dec 1, 2015 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: